Abnet CC, Arnold M, Wei WQ (2018) Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 154(2):360–373

PubMed  Google Scholar 

Angèle S et al (2004) ATM protein overexpression in prostate tumors: possible role in telomere maintenance. Am J Clin Pathol 121(2):231–236

PubMed  Google Scholar 

Chen M et al (2018) Long noncoding RNA FAM201A mediates the radiosensitivity of esophageal squamous cell Cancer by regulating ATM and mTOR expression via miR-101. Front Genet 9:611

CAS  PubMed  PubMed Central  Google Scholar 

Chen S et al (2023) JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis. Oncogene 42(37):2737–2750

CAS  PubMed  PubMed Central  Google Scholar 

Cremona CA, Behrens A (2014) ATM Signal cancer Oncogene 33(26):3351–3360

CAS  PubMed  Google Scholar 

Dahl ES, Aird KM (2017) Ataxia-Telangiectasia mutated modulation of carbon metabolism in Cancer. Front Oncol 7:291

PubMed  PubMed Central  Google Scholar 

Dale B et al (2021) Advancing targeted protein degradation for cancer therapy. Nat Rev Cancer 21(10):638–654

CAS  PubMed  PubMed Central  Google Scholar 

DiSiena M et al (2021) Esophageal cancer: an updated review. South Med J 114(3):161–168

PubMed  Google Scholar 

Han J et al (2014) SIVA1 directs the E3 ubiquitin ligase RAD18 for PCNA monoubiquitination. J Cell Biol 205(6):811–827

CAS  PubMed  PubMed Central  Google Scholar 

Hanisch D et al (2022) Class I HDAC overexpression promotes Temozolomide resistance in glioma cells by regulating RAD18 expression. Cell Death Dis 13(4):293

CAS  PubMed  PubMed Central  Google Scholar 

Ji F et al (2021) Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis. Cancer Commun (Lond) 41(10):1007–1023

PubMed  Google Scholar 

Khatoon E et al (2022) The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer. Arch Pharm Res 45(8):507–534

CAS  PubMed  Google Scholar 

Lee JH, Paull TT (2021) Cellular functions of the protein kinase ATM and their relevance to human disease. Nat Rev Mol Cell Biol 22(12):796–814

CAS  PubMed  Google Scholar 

Li P et al (2020) RAD18 promotes colorectal cancer metastasis by activating the epithelial–mesenchymal transition pathway. Oncol Rep 44(1):213–223

CAS  PubMed  PubMed Central  Google Scholar 

Li X et al (2022) RAD18 confers radioresistance of esophagus squamous cell carcinoma through regulating p-DNA-PKcs. Cancer Med 11(20):3809–3819

CAS  PubMed  PubMed Central  Google Scholar 

Liu TT et al (2022) Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy. EBioMedicine 86:104353

CAS  PubMed  PubMed Central  Google Scholar 

Liu J et al (2023) The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer. J Clin Invest, 133(6): e164354

Lou P et al (2019) RAD18 contributes to the migration and invasion of human cervical cancer cells via the interleukin–1β pathway. Mol Med Rep 20(4):3415–3423

CAS  PubMed  Google Scholar 

Lu C et al (2017) JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer. Oncoimmunology 6(3):e1291106

PubMed  PubMed Central  Google Scholar 

Lv J et al (2023) Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade. Int J Biol Sci 19(12):3744–3761

CAS  PubMed  PubMed Central  Google Scholar 

Ma RJ et al (2022) Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review). Int J Oncol, 61(3): 105

Neeb A et al (2021) Advanced prostate Cancer with ATM loss: PARP and ATR inhibitors. Eur Urol 79(2):200–211

CAS  PubMed  Google Scholar 

Overstreet JM et al (2015) Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-β1 in orchestrating profibrotic responses. Faseb J 29(4):1258–1268

CAS  PubMed  Google Scholar 

Pamment J et al (2002) Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. Oncogene 21(51):7776–7785

CAS  PubMed  Google Scholar 

Rutegård M et al (2012) Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update. Surgery 152(5):903–910

PubMed  Google Scholar 

Shen M et al (2019) Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway. J Exp Clin Cancer Res 38(1):149

PubMed  PubMed Central  Google Scholar 

Sung H et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249

PubMed  Google Scholar 

Terlizzi C et al (2023) ATM Inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors. Cancer Metab 11(1):20

PubMed  PubMed Central  Google Scholar 

Williams SA et al (2011) The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI. Blood 117(19):5078–5087

CAS  PubMed  PubMed Central  Google Scholar 

Wong RP et al (2012) Elevated expression of Rad18 regulates melanoma cell proliferation. Pigment Cell Melanoma Res 25(2):213–218

CAS  PubMed  Google Scholar 

Wu J et al (2019) IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma. J Exp Clin Cancer Res 38(1):321

PubMed  PubMed Central  Google Scholar 

Wu N et al (2021) LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway. Cell Death Differ 28(1):219–232

CAS  PubMed  Google Scholar 

Xie C et al (2019) Knockdown of RAD18 inhibits glioblastoma development. J Cell Physiol 234(11):21100–21112

CAS  PubMed  Google Scholar 

Yang Y et al (2018) Diverse roles of RAD18 and Y-family DNA polymerases in tumorigenesis. Cell Cycle 17(7):833–843

CAS  PubMed  PubMed Central  Google Scholar 

Yang Y et al (2024) Gancao Xiexin Decoction inhibits gastric carcinoma proliferation and migration by regulating the JAK2/STAT3 signalling pathway. J Ethnopharmacol 319(Pt 2):117241

CAS  PubMed  Google Scholar 

Yi M et al (2022) Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. Mol Cancer 21(1):28

PubMed  PubMed Central  Google Scholar 

Zeng X et al (2022) UBE2B promotes ovarian cancer growth via promoting RAD18 mediated ZMYM2 monoubiquitination and stabilization. Bioengineered 13(4):8000–8012

CAS  PubMed  PubMed Central  Google Scholar 

Zhang C et al (2019) Upregulation of long noncoding RNA SNHG20 promotes cell growth and metastasis in esophageal squamous cell carcinoma via modulating ATM-JAK-PD-L1 pathway. J Cell Biochem 120(7):11642–11650

CAS  PubMed  Google Scholar 

Zhang R et al (2020) EphA5 Silencing increases the radiosensitivity of ESCC cells through ATM-Dependent pathway. Cancer Manag Res 12:9539–9549

CAS  PubMed  PubMed Central  Google Scholar 

Zhou S et al (2021) MET Inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways. J Cell Mol Med 25(24):11157–11169

CAS  PubMed  PubMed Central  Google Scholar 

Zhou Y et al (2023a) ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer. Sci Adv 9(47):eadg2263